Eastern Equine Encephalomyelitis Virus Infection in a Horse from California

• Main Authors: Robert P. Franklin, Hailu Kinde, Michele T. Jay, Laura D. Kramer, Emily-Gene N. Green, Robert E. Chiles, Eileen Ostlund, Stan Husted, Jonathan Smith, Michael D. Parker
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2002-03-01
• Series: Emerging Infectious Diseases
• Subjects: Alphavirus; Arbovirus; California; Encephalitis; Reverse Transcription-Polymerase Chain Reaction; Togavirus
• Online Access: https://wwwnc.cdc.gov/eid/article/8/3/01-0199_article

A yearling quarter horse, which was raised in southern California, received routine vaccinations for prevention of infection by Eastern equine encephalomyelitis virus (EEEV). One week later, severe neurologic signs developed, and the horse was humanely destroyed because vaccine-related encephalomyelitis was suspected. A final diagnosis of EEEV infection was established on the basis of acute onset of the neurologic signs, histopathologic and serologic testing, and isolation and molecular characterization of EEEV from brain tissue. The vaccine was extensively tested for viral inactivation. Nucleotide sequences from the vaccine and the virus isolated in the affected horse were also compared. In California, arboviral encephalomyelitides are rarely reported, and EEEV infection has not previously been documented. This report describes the occurrence of EEEV infection in the horse and the investigation to determine the source of infection, which was not definitively identified.